Advertisement

Topics

BridgeBio launches another biotech, focused on gene disorders

03:52 EDT 14 Jun 2018 | BioPharmaDive

CoA Therapeutics, the second subsidiary BridgeBio has rolled out this month, aims to create drugs for diseases linked to coenzyme-A deficiencies.

Original Article: BridgeBio launches another biotech, focused on gene disorders

NEXT ARTICLE

More From BioPortfolio on "BridgeBio launches another biotech, focused on gene disorders"

Advertisement
Quick Search
Advertisement
Advertisement